Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females clinical trial (NCT01301456). Contact the study team or your healthcare provider for specific answers.

Question 2

How does PF-04856883 compare to my current diabetes treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females clinical trial (NCT01301456). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with this new treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females clinical trial (NCT01301456). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females clinical trial (NCT01301456). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females clinical trial (NCT01301456). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my diabetes management be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females clinical trial (NCT01301456). Contact the study team or your healthcare provider for specific answers.

What this study is about